Skip to content

Prime Medicine PRME Business Segments — Operating Expenses

Similar metrics at other companies

Indivior Pharmaceuticals, Inc.
 logo
INDVReportable Segment — Operating Expenses
$139M-10.9%
Andersen Group
 logo
ANDGReportable Segment — Operating Expenses
$216.67M+39.4%
Shutterstock logo
SSTKReportable Segment — Operating Expenses
$230.12M-1.0%
Vaxcyte, Inc. logo
PCVXReportable Segment — Operating Expenses
$345.85M+91.3%
ITG
ITGRReportable Segment — Operating Expenses
$69.78M+11.3%
Global Business Travel Group logo
GBTGReportable Segment — Operating Expenses
$691M+44.0%

Other financials

Income statement

See full
Revenue$838.0K-61.6%
Operating income-$50.7M+3.3%
Net income-$49.1M+5.3%
EPS (diluted)-$0.28+30.0%

Balance sheet

See full
Cash & equivalents$77.8M-26.6%
Total debt$114.5M-5.5%
Total equity$76.7M-28.3%
Total assets$294.7M-10.2%

Cash flow

See full
Operating cash flow-$42.7M+12.6%
CapEx$214.0K-91.2%
Free cash flow-$42.9M+16.3%

Valuation

See full
Market cap$574.36M+111%
Enterprise value$611.08M+113%
P/S124×+6.3×

Profitability

See full
Operating margin-4,498.1%-1,134pp
Net margin-4,342.4%-1,099pp
FCF margin-3,607.4%

Returns & leverage

See full
Return on equity-216.1%+1,519pp
Debt / equity1.5×+0.4×
Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's business segments — operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prime Medicine's business segments — operating expenses?
Prime Medicine (PRME) reported business segments — operating expenses of $51.51M in Q1 2026.
How has Prime Medicine's business segments — operating expenses changed year-over-year?
Prime Medicine's business segments — operating expenses decreased by 4.3% year-over-year, from $53.85M to $51.51M.
What is the long-term trend for Prime Medicine's business segments — operating expenses?
Over 2 years (2023 to 2025), Prime Medicine's business segments — operating expenses has grown at a 2.0% compound annual growth rate (CAGR), from $204.79M to $212.98M.
What does business segments — operating expenses mean?
The aggregate of all costs incurred to operate a specific business segment, including personnel, facilities, research, and other administrative expenses. This metric provides a comprehensive view of the segment's total burn rate or operational cost burden. It is essential for evaluating the segment's cost management and operational efficiency.